B-CELL MATURATION ANTIGEN TARGETING STRATEGIES IN MULTIPLE MYELOMA TREATMENT, ADVANTAGES AND DISADVANTAGES

Abstract cardinals 3.14 flash sale B cell maturation antigen (BCMA), a transmembrane glycoprotein member of the tumor necrosis factor receptor superfamily 17 (TNFRSF17), highly expressed on the plasma cells of Multiple myeloma (MM) patients, as well as the normal population.BCMA is used as a biomarker for MM.Two members of the TNF superfamily prote

The article summarizes the main concepts of the policy of protectionism.It was proved that the shaded or semi-open nature of protectionism of the 21st century model does not fall under classical manifestations of protectionism recorded in the WTO documents, and therefore further hybridization of its forms actualizes the need for their classificatio